Neuropathy Clinical Trials in New York, New York
17 recruitingNew York, New York
Showing 1–17 of 17 trials
Recruiting
Phase 3
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
Chronic Inflammatory Demyelinating PolyradiculoneuropathyPolyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi140 enrolled131 locationsNCT06290128
Recruiting
Phase 3
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Hereditary Transthyretin-Mediated Amyloidosis With PolyneuropathyhATTR-PN
Alnylam Pharmaceuticals125 enrolled29 locationsNCT07223203
Recruiting
Not Applicable
The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
Chemotherapy-induced Peripheral Neuropathy (CIPN)
Luminate Medical, Inc.142 enrolled18 locationsNCT07142304
Recruiting
Phase 2
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyneuropathy
Immunovant Sciences GmbH162 enrolled135 locationsNCT07032662
Recruiting
Phase 2Phase 3
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Janssen Research & Development, LLC201 enrolled115 locationsNCT05327114
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Chronic Inflammatory Demyelinating Polyneuropathy
Dianthus Therapeutics256 enrolled168 locationsNCT06858579
Recruiting
Phase 3
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyneuropathy
Sanofi160 enrolled123 locationsNCT06290141
Recruiting
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Urothelial CarcinomaMetastatic Urothelial CarcinomaNeuropathy
Memorial Sloan Kettering Cancer Center50 enrolled7 locationsNCT07390617
Recruiting
Phase 1
Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
Open-angle Glaucoma (OAG)NAION( Non-arteritic Anterior Ischemic Optic Neuropathy)
Life Biosciences Inc.18 enrolled4 locationsNCT07290244
Recruiting
Phase 3
A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
Grifols Therapeutics LLC40 enrolled5 locationsNCT07540221
Recruiting
Phase 2
SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.
painful peripheral neuropathyChemotherapy-induced Peripheral Neuropathy (CIPN)Diabetic Peripheral Neuropathic Pain (DPN)+1 more
University of Rochester190 enrolled7 locationsNCT06614322
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
Multifocal Motor Neuropathy (MMN)MMN
argenx115 enrolled109 locationsNCT06742190
Recruiting
Not Applicable
Repetitive Transorbital Alternating Current Stimulation for Optic Neuropathies
Optic Neuropathy
NYU Langone Health70 enrolled1 locationNCT06662448
Recruiting
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Blood PressureNeuropathyDiabetes+6 more
Jaeb Center for Health Research200 enrolled18 locationsNCT06837181
Recruiting
Phase 3
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda59 enrolled52 locationsNCT06747351
Recruiting
The Natural History of Familial Dysautonomia
Familial Dysautonomia (Riley-Day Syndrome)Hereditary Sensory and Autonomic NeuropathiesHereditary Sensory and Autonomic Neuropathy 3
NYU Langone Health400 enrolled2 locationsNCT03920774
Recruiting
International CIPN Assessment and Validation Study
Chemotherapy Induced Peripheral NeuropathyQuality of Life
University of Milano Bicocca1,000 enrolled30 locationsNCT04633655